U.S. cancer centers are scrambling to enroll patients in an early access program for a highly promis...
US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug
U.S. cancer centers are scrambling to enroll patients in an early access program for a highly promising pancreatic cancer drug from Revolution Medicines...
Author: Reuters
Read Original Article